- Home
- Meetings
- Highlights of Past EHA (HOPE) Cairo 2018
- Meeting program
Meeting program
14:30 - 15:00 Opening ceremony Chairs: J Gribben (EHA), M Qari (PAHA) & A El-Beshlawy (ESHR) 15:00 - 16:30 SCIENTIFIC SESSION Laboratory hematology Chair: A Kamel (ESHR) 16:30 - 17:00 ABSTRACT PITCH SESSION 1 Chair: JB Hansen (Norway) 17:00 - 17:30 Coffee break 17:30 - 18:30 BMS SATELLITE SYMPOSIUM New horizons in cancer immunotherapy, Management of cHL 18:30 - 19:30 Welcome reception & Poster session 09:30 - 10:30 SCIENTIFIC SESSION Acute & Chronic Leukemia Chair: H Özsan (TSH) 10:30 - 11:30 SCIENTIFIC SESSION Hemoglobinopathies Chair: A El-Beshlawy (ESHR) 11:30 - 13:30 Prayer, lunch & poster viewing 12:30 - 13:30 BMS SATELLITE SYMPOSIUM Treatment advances in hematological malignancies 13:30 - 15:00 JOINT SYMPOSIUM Regional perspectives on hemoglobinopathies Chair: M Qari (PAHA) 15:00 - 16:00 SCIENTIFIC SESSION Lymphoma Chair: S Al Jaouni (SSH) 16:00 - 16:30 Coffee break 16:30 - 18:00 SCIENTIFIC SESSION Red cells & iron Chair: A Ibrahim (LSHBT) 18:00 - 18:45 ABSTRACT PITCH SESSION 2 Chair: J Gribben (United Kingdom) 09:30 - 10:15 SCIENTIFIC SESSION Multiple myeloma Chair: WF Al Tameemi (ISOH) 10:15 - 11:00 ABSTRACT PITCH SESSION 3 Chair: O Ottmann (United Kingdom) 11:00 - 11:30 Coffee break 11:30 - 12:30 SCIENTIFIC SESSION Thrombosis & hemostasis Chair to be announced 12:30 - 13:00 Closing ceremony Chair: P Sonneveld (EHA), M Qari (PAHA) & A Kamel (ESHR) 13:00 - 14:00 Farewell lunch
Thursday, September 27
MC Béné (France)
A Orfao (Spain)
J Trka (Czech Republic)
Y El Chazli (Alexandria University Children's Hospital, Egypt)
M Hesham (Zagazig University, Egypt)
S Bakr (Faculty of Medicine, Fayoum University, Egypt)
AAT Tantawy (Faculty of Medicine Ain Shams University, Cairo, Egypt)
NF Osman (Menoufia University, Egypt)
T Elgemmezi (Blood Transfusion Services - Kauh - Jeddah, Saudi Arabia)
RF Raghda Fouda (Cairo University, Kasr Alainy, Egypt)
H AbdelAzim (Egypt)
Friday, September 28
G Gaidano (Italy)
J Gribben (United Kingdom)
O Ottmann (United Kingdom)
A Nai (Italy)
M Abboud (Lebanon)
A AlGhandour (Egypt)
A AlGhandour (Egypt)
J Gribben (EHA)
A Radhi (Bahrain)
T Owaidah (Saudi Arabia)
Ş Unal (Turkey)
H Al-Momen (Iraq)
A El-Beshlawy (Egypt)
S Alkindi (Oman)
F D'Amore (Denmark)
M Federico (Italy)
D Girelli (Italy)
J Davies (United Kingdom)
H Drakesmith (United Kingdom)
SA Ahmed (Internal Medicine Department, Qena University Hospital, Qena, Egypt)
MA Al-Mashta (Department of Haematopathology, Iraq)
E NasrEldin (Assiut University - Faculty of Medicine - Clinical Pathology Department, Egypt)
MD Denewer (Oncology Center of Mansoura University, Egypt)
S El-Ashwah (Mansoura University, Mansoura, Egypt)
EJ Jamal (Internal Medicine Department - Faculty of Medicine - Mansoura University, Egypt)
ME Elbogdady (Oncology Center Mansoura University, Egypt)
MM Omran (National Cancer Institute - Cairo University, Egypt)
DD Salem (Faculty of Medicine, Ain Shams University, Egypt)
I Osman (Al Neelain University, Sudan)
LMS Saleh (Hematology Section, Clinical Pathology Department, Faculty of Medicine, Mansoura University, Egypt)
Saturday, September 29
P Sonneveld (The Netherlands)
HG El-Khoury (American University of Beirut, Lebanon)
SH El Ashwah (Mansoura University, Mansoura, Egypt)
SF Gohar (Faculty of Medicine, Menoufia University, Egypt)
JB Hansen (Norway)
P Morange (France)